Acadia Trust’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
Acadia Trust's TEVA Position: Q1 2015 in Review
Acadia Trust sold out of Teva Pharmaceutical Industries (TEVA) in Q1 2015, closing a stake of 3,766 shares — an estimated $217K sold.
Acadia Trust first reported a position in TEVA in Q2 2013 and held it in 7 quarters. The position peaked at $8.39M in Q1 2014. 822 funds tracked by Wall St. Rank hold TEVA as of Q1 2015.
- Acadia Trust reported no remaining Teva Pharmaceutical Industries position as of Q1 2015 after selling out during the quarter.
- Acadia Trust sold 3,766 Teva Pharmaceutical Industries shares in Q1 2015, an estimated $217K.
- Acadia Trust first reported a position in Teva Pharmaceutical Industries in Q2 2013 and held it in 7 quarters.
- Acadia Trust's Teva Pharmaceutical Industries position peaked at $8.39M in Q1 2014.
- 822 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q1 2015.
Based on Acadia Trust's 13F filing for Q1 2015, filed 11 May 2015.